𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia

✍ Scribed by Philip D Harvey; Herbert Meltzer; George M Simpson; Steven G Potkin; Antony Loebel; Cynthia Siu; Steven J Romano


Book ID
119362068
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
217 KB
Volume
66
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effects of switching to long-acting inje
✍ Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Seung-Hyun Lee; Yo-Han Lee; Su-Jin Yang πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to long‐acting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirty‐six patients with schizophrenia treated with oral

The impact upon extra-pyramidal side eff
✍ C. W. Ritchie; E. Chiu; S. Harrigan; K. Hall; A. Hassett; S. Macfarlane; M. Mast πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

## Abstract ## Background Atypical antipsychotics are commonly used in the management of schizophrenia in late life with evidence suggesting they induce lower rates of motor disturbance, but have similar efficacy to conventional antipsychotics. Trials in the elderly have been either retrospective,